Alimera Sciences to Present at the H.C. Wainwright 2nd Annual Ophthalmology Virtual Conference

Aug 10th, 2022 8:00 EST

ATLANTA, Aug. 10, 2022 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer, announced today that Rick Eiswirth, Alimera’s President and Chief Executive Officer, will deliver a corporate presentation at the HC Wainwright 2nd Annual Ophthalmology Conference being held virtually on Wednesday, August 17, 2022.

The presentation will be available on demand at 7:00am ET on August 17, 2022. In addition to the presentation, management will be available for one-on-one meetings with investors who are registered to attend the conference.

Register here: https://hcwevents.com/ophthalmologyconference/

About Alimera Sciences, Inc.

www.alimerasciences.com

Alimera Sciences is a global pharmaceutical company whose mission is to be invaluable to patients, physicians and partners concerned with retinal health and maintaining better vision longer. For more information, please visit www.alimerasciences.com.

For press inquiries:Jules Abrahamfor Alimera Sciences 917-885-7378[email protected]For investor inquiries:Scott Gordonfor Alimera Sciences[email protected]

SHARE

You must be logged in to post a comment.

Related Recent Publications

You must be logged in to post a comment.

Email newsletter

Receive the latest stock news and signals